LSP-249
CAS No. 1801253-04-2
LSP-249( —— )
Catalog No. M23814 CAS No. 1801253-04-2
LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 36 | In Stock |
|
5MG | 58 | In Stock |
|
10MG | 87 | In Stock |
|
25MG | 177 | In Stock |
|
50MG | 295 | In Stock |
|
100MG | 484 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLSP-249
-
NoteResearch use only, not for human use.
-
Brief DescriptionLSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
-
DescriptionLSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorkallikrein
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1801253-04-2
-
Formula Weight431.92
-
Molecular FormulaC24H22ClN5O
-
Purity>98% (HPLC)
-
SolubilityDMSO:31.25 mg/mL?(69.45 mM;?ultrasonic and warming and heat to 60°C)
-
SMILESCc1cc(N)nc(C)c1CNC(c1cc(Cc2ccc3ncc(Cl)cc3c2)ncc1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Andrew Mcdonald, et al. Therapeutic inhibitory compounds. Patent. WO2016011209A1.
molnova catalog
related products
-
Iprindole
Iprindole, a tricyclic indole antidepressant, is a weak inhibitor of the uptake of noradrenaline and 5-HT.
-
Dihydrocatalpol
Dihydrocatalpol,a natural product obtained from the herbs of Rehmannia glutinosa.
-
PBIT
PBIT inhibits JARID1B histone demethylase (IC50 of about 3 μM). PBIT also inhibits JARID1A and JARID1C (IC50s of 6 μM and 4.9 μM, respectively). PBIT is a specific inhibitor of the Jumonji AT-rich Interactive Domain 1 (JARID1) enzymes . PBIT, which inhibits JARID1B with an IC50 of about 3 μm in vitro.